持续气道正压通气

  • 网络cPAP;NCPAP;Continuous Positive Airway Pressure
持续气道正压通气持续气道正压通气
  1. 无创持续气道正压通气治疗COPD患者的护理问题与措施

    Nursing Precautions During Non-invasive CPAP Treatment of COPD Patients

  2. 经持续气道正压通气(CPAP)治疗、纠正睡眠呼吸暂停6~8周后,晨起血压较治疗前明显下降(P<0.001)。

    After CPAP for 6 ~ 8 weeks , the blood pressure after sleep in the morning was significantly decreased as compared with that before treatment ( P < 0.001 ) .

  3. SAS病人持续气道正压通气治疗前后记忆和情绪改变

    The change of memory and emotion disorder in the SAS after treatment

  4. 持续气道正压通气治疗OSA的疗效评价

    Effect of nasal continuous positive airway pressure in patients with obstructive sleep apnea

  5. 声音2:另一种设备名为持续气道正压通气系统(简称CPAP)。

    Voice 2 : Another device is called a CPAP .

  6. 鼻持续气道正压通气压力0.588~1.176kPa,每日6~8h。

    The pressure of nasal continuous positive airway was 0.588-1.176 kPa for 6-8 hours every day .

  7. CPAP指的是持续气道正压通气。当病人入睡的时候,向病人的喉咙和肺部输入持续的气流。

    CPAP is positive airway pressure . It provides a continuous flow of air into the throat and lungs while the person sleeps .

  8. 目的探讨更适用于持续气道正压通气(NCPAP)治疗的雾化吸药方法。

    Objective To explore the proper method of aerosol inhalation during nasal continuous positive airway pressure ventilation ( NCPAP ) .

  9. 向感兴趣的患者解释睡眠呼吸暂停的标准治疗是在睡眠时通过一个面罩提供持续气道正压通气(CPAP)。

    Explain to interested patients that the standard treatment for sleep apnea is to provide continuous positive airway pressure , or CPAP , through a mask worn during sleep .

  10. 本研究比较中、重度阻塞型睡眠呼吸暂停综合征(OSAS)患者经鼻持续气道正压通气(nCPAP)短期治疗前后血清ICAM-1水平有无差别。

    We investigated the effects of nasal continuous positive airway pressure ( nCPAP ) treatment on serum level of ICAM-I in moderate to severe obstructive sleep apnea syndrome ( OSAS ) patients .

  11. 单纯氧疗与持续气道正压通气对慢性充血性心力衰竭Cheyne-Stokes呼吸的作用

    Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration in patients with chronic congestive heart failure

  12. 目的观察无创持续气道正压通气(NCPAP)治疗新生儿早期呼吸障碍的有效性及安全性。

    Objective To study the effect and safety of nasal continuous positive airway pressure ( NCPAP ) in the treatment of early respiratory disorders in newborn .

  13. 目的评估自动调节持续气道正压通气(auto-CPAP)治疗阻塞性睡眠呼吸暂停(OSA)的疗效。

    Objective To determine the efficacy of an auto continuous positive airways pressure ( auto CPAP ) treatment in patients with obstructive sleep apnea ( OSA ) .

  14. 目的观察大剂量盐酸氨溴索联合可变流量鼻罩持续气道正压通气治疗新生儿肺透明膜病(HMD)的效果。

    Objective : To investigate the therapeutic effect of large dose Ambroxol Hydrochloride combining variant flow rate continuous positive airway by nasal mask to hyaline membrane disease of newborn ( HMD ) .

  15. 常规抗感染治疗无效,中毒症状明显和肺部阴影扩散时,及时应用持续气道正压通气(CPAP)和皮质激素可有效控制病情发展。

    Continual positive airway pressure ( CPAP ) and glucocorticoid was required that can control depravation of the disease when toxicosis symptom of patients was severity and shadow of lungs diffuse more and more .

  16. 目的观察经鼻持续气道正压通气(nCPAP)短期治疗对顽固性高血压合并中重度阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者血压及血清高敏C反应蛋白(hs-CRP)的影响。

    Objective To investigate the effect of nasal continuous positive airway pressure ( nCPAP ) short-term treatment on blood pressure and the level of serum high-sensitivity c-reactive protein ( hs-CRP ) in refractory hypertension patients complicated with moderate or severe obstructive sleep apnea-hypopnea syndrome ( OSAHS ) .

  17. 目的:分析评价经鼻持续气道正压通气(nCPAP)治疗阻塞性睡眠呼吸暂停低通气综合征(OSAHS)伴高血压的远期疗效。

    Objective : To analyze and evaluate a long-term curative effect of nasal continuous positive airway ( pres - ) sure ( nCPAP ) in treatment of patients with obstructive sleep apnea hypopnea syndrome ( OSAHS ) accompanying hypertension .

  18. 目的探讨可变流量经鼻持续气道正压通气(VF-NCPAP)加氨茶碱治疗早产儿呼吸衰竭的疗效。

    Objective To study the effects of variable-flow nasal continuous positive airway pressure ( VF-NCPAP ) and aminophylline on preterm neonates with respiratory failure .

  19. 目的经鼻持续气道正压通气(nCPAP)治疗高血压合并阻塞性睡眠呼吸暂停低通气综合征(OS-AHS)患者,以评价该疗法对血压和睡眠呼吸监测参数的影响。

    Objective To evaluate the efficacy of nasal continuous positive airway pressure ( nCPAP ) on the blood pressure and the parameters of sleep respiration in patients of hypertension complicated with obstructive sleep apnea-hypopnea syndrome ( OSAHS ) .

  20. 方法两组患者的最适持续气道正压通气(CPAP)治疗压力及压力耐受性均在患者睡眠时测定,于非快动眼睡眠(NREM)及快动眼睡眠(REM)期分别进行。

    Methods The appropriation to CPAP therapy pressure and the tolerance to CPAP pressure of two group patients were tested during sleep CPAP titration . These statistics were separately collected during non-rapid eye movement ( NREM ) and rapid eye movement ( REM ) .

  21. 由于经鼻塞持续气道正压通气(N-CPAP)具有创伤小、费用低、并发症少等优点,广泛用于新生儿呼吸衰竭的治疗。

    Nasal continuous positive airway pressure ( N-CPAP ) has been widely applied for neonatal respiratory failure cases because of its merits such as little invasion , low cost , and few complications .

  22. 如今,迈克使用了持续气道正压通气系统,他再也不打鼾了。

    Today , Mike uses a CPAP and he no longer snores .

  23. 经鼻面罩持续气道正压通气对支气管哮喘疗效的观察

    Effect of nasal / face mask continuous positive airway pressure in bronchial asthma

  24. 结论持续气道正压通气是治疗重叠综合征的有效方法。

    Conclusion Continuous positive airway pressure is an effective method to treat overlap syndrome .

  25. 持续气道正压通气模式治疗低氧血症78例临床观察

    Clinical application of mask continuous positive airway pressure ventilation in patients with acute respiratory failure

  26. 鼻塞持续气道正压通气治疗早产儿原发性呼吸暂停的临床观察

    Clinical Observation of Nasal Continuous Positive Airway Pressure ( nCPAP ) Treatment on Primary Apnea of Prematurity

  27. 目的观察持续气道正压通气对重叠综合征的疗效。

    Objective To study the validity of continuous positive airway pressure ( CPAP ) curing overlap syndrome .

  28. 肺表面活性物质与鼻塞持续气道正压通气联合治疗肺透明膜病疗效观察

    The effect of pulmonary surfactant in company with nasal continuous positive airway pressure treatment on pulmonary hyaline membrane disease

  29. 持续气道正压通气、T管及压力支持通气等条件下患者呼吸功的比较性研究

    Comparison of work of breathing among continuous positive airway pressure ventilation , T tube and pressure support ventilation in patients

  30. 肺表面活性物质联合鼻塞持续气道正压通气治疗新生儿呼吸窘迫综合征疗效观察

    Observation on the effect of pulmonary surfactants and nasal continuous positive airway pressure replacement therapy on neonatal respiratory distress syndrome